Dr. Manuel Marina-Breysse is a cardiologist and the co-founder & CEO of Idoven, a European deep tech-AI company pioneering early detection and precision medicine in cardiology. He leads a multidisciplinary team developing AI models for ECG interpretation, enabling earlier, faster, and more precise diagnosis of cardiovascular conditions worldwide.

Under his leadership, Idoven has built Willem™, an AI-powered ECG interpretation platform adopted by global leaders and secured partnerships with companies such as AstraZeneca and Abbott. The company’s mission is to prevent heart disease globally through scalable, ethical, and clinically validated artificial intelligence.

Dr. Marina-Breysse is a recognized speaker and contributor at leading events including HLTH Europe, ESC Congress, and Google Forward Magazine. His work continues to redefine how heart diseases are detected and prevented, advancing the field of digital health and cardiovascular care.